[ESPR] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -21.74%
YoY- -13.79%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 184,474 0 0 0 0 0 0 -
PBT -60,039 -49,911 -45,730 -46,130 -37,891 -45,219 -43,337 24.20%
Tax -74 0 0 0 807 606 433 -
NP -60,039 -49,911 -45,730 -46,130 -37,891 -45,219 -43,337 24.20%
Tax Rate - - - - - - - -
Total Cost 244,513 49,911 45,730 46,130 37,891 45,219 43,337 215.93%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -32.55 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -2.24 -1.86 -1.71 -1.73 -1.44 -1.86 -1.92 10.79%
EPS Diluted -2.24 -1.86 -1.71 -1.73 -1.44 -1.86 -1.92 10.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.